What is she best known for?
The fields of study she is best known for:
Her primary areas of investigation include Genetics, Biochemistry, Cancer research, HDAC4 and Histone deacetylase 2.
Her studies deal with areas such as Monocyte and Cell biology as well as Biochemistry.
The various areas that she examines in her Cell biology study include Caspase, Bcl-2 Homologous Antagonist-Killer Protein and Bcl-2 family.
The study incorporates disciplines such as Histone deacetylase 5, Histone deacetylase activity and HDAC10 in addition to HDAC4.
Annick Harel-Bellan interconnects Retinoblastoma protein and Histone acetyltransferase in the investigation of issues within Histone deacetylase 2.
Annick Harel-Bellan focuses mostly in the field of Regulation of gene expression, narrowing it down to topics relating to Autophagy and, in certain cases, Gene silencing.
Her most cited work include:
- Retinoblastoma protein represses transcription by recruiting a histone deacetylase (861 citations)
- The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation (494 citations)
- A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease (428 citations)
What are the main themes of her work throughout her whole career to date?
Annick Harel-Bellan mainly focuses on Molecular biology, Cell biology, Oligonucleotide, Biochemistry and Genetics.
Her research on Molecular biology also deals with topics like
- Transcription factor which intersects with area such as Myocyte,
- Nucleic acid most often made with reference to Transcription.
Annick Harel-Bellan has included themes like Cellular differentiation, Chromatin, RNA interference, microRNA and DNA replication in her Cell biology study.
Her research in microRNA intersects with topics in Gene silencing, Downregulation and upregulation, Computational biology and Bioinformatics.
Her Oligonucleotide study incorporates themes from Enhancer, Nucleotide and Triple helix.
Her is involved in several facets of Genetics study, as is seen by her studies on Regulation of gene expression, RNA splicing and Argonaute.
She most often published in these fields:
- Molecular biology (49.29%)
- Cell biology (32.86%)
- Oligonucleotide (14.29%)
What were the highlights of her more recent work (between 2011-2020)?
- microRNA (15.71%)
- Cell biology (32.86%)
- Genetics (17.86%)
In recent papers she was focusing on the following fields of study:
Annick Harel-Bellan mostly deals with microRNA, Cell biology, Genetics, Computational biology and Cancer research.
Her microRNA study combines topics in areas such as Cellular differentiation, Bioinformatics, Molecular biology, Myocyte and Gene silencing.
Her biological study spans a wide range of topics, including EEF1A2, Eukaryotic translation elongation factor 1 alpha 1, Elongation factor, Transfection and Eukaryotic translation.
Her studies in Cell biology integrate themes in fields like RNA interference, Regulation of gene expression, Cell type, Programmed cell death and Adenocarcinoma.
Her primary area of study in Genetics is in the field of RNA splicing.
Annick Harel-Bellan combines subjects such as Carcinogenesis, Apoptosis, Immunology, Biomarker and Breast cancer with her study of Cancer research.
Between 2011 and 2020, her most popular works were:
- Argonaute proteins couple chromatin silencing to alternative splicing (211 citations)
- Kinetic signatures of microRNA modes of action (94 citations)
- Kinetic signatures of microRNA modes of action (94 citations)
In her most recent research, the most cited papers focused on:
Her primary areas of study are microRNA, Cancer research, Bioinformatics, Immunology and Context.
Her microRNA research includes elements of Elongation factor, Downregulation and upregulation, Transfection, Eukaryotic translation and Molecular biology.
Annick Harel-Bellan has researched Cancer research in several fields, including DNA damage, Cancer cell, Apoptosis and Stem cell, Neural stem cell.
Her Stem cell research incorporates elements of Carcinogenesis, Breast cancer, Signal transduction and Cellular differentiation.
Her work deals with themes such as Tumor progression, Gene silencing and Wnt signaling pathway, which intersect with Bioinformatics.
Her Immunology research integrates issues from Biomarker, Lung cancer and In vivo.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
